Trials / Conditions / Bipolar I Depression
Bipolar I Depression
6 registered clinical trials studyying Bipolar I Depression.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression NCT04383691 | Sumitomo Pharma (Suzhou) Co., Ltd. | Phase 3 |
| Active Not Recruiting | Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder NCT03336918 | Brigham and Women's Hospital | — |
| Completed | Lurasidone Pediatric Bipolar Study NCT02046369 | Sumitomo Pharma America, Inc. | Phase 3 |
| Completed | Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression NCT01403662 | University Health Network, Toronto | Phase 3 |
| Completed | A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression NCT00812058 | Repligen Corporation | Phase 2 |
| Completed | Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder NCT00481195 | Cephalon | Phase 2 |